Literature DB >> 31142465

Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial.

Carly Siu Yin Lam1, Wing Chun Tang2, Dennis Yan-Yin Tse2, Roger Pak Kin Lee2, Rachel Ka Man Chun2, Keigo Hasegawa3, Hua Qi3, Takashi Hatanaka3, Chi Ho To2.   

Abstract

AIM: To determine if 'Defocus Incorporated Multiple Segments' (DIMS) spectacle lenses slow childhood myopia progression.
METHODS: A 2-year double-masked randomised controlled trial was carried out in 183 Chinese children aged 8-13 years, with myopia between -1.00 and -5.00 D and astigmatism ≤1.50 D. Children were randomly assigned to wear DIMS (n=93) or single vision (SV) spectacle lenses (n=90). DIMS lens incorporated multiple segments with myopic defocus of +3.50 D. Refractive error (cycloplegic autorefraction) and axial length were measured at 6month intervals.
RESULTS: 160 children completed the study, n=79 in the DIMS group and n=81 in the SV group. Average (SE) myopic progressions over 2 years were -0.41±0.06 D in the DIMS group and -0.85±0.08 D in the SV group. Mean (SE) axial elongation was 0.21±0.02 mm and 0.55±0.02 mm in the DIMS and SV groups, respectively. Myopia progressed 52% more slowly for children in the DIMS group compared with those in the SV group (mean difference -0.44±0.09 D, 95% CI -0.73 to -0.37, p<0.0001). Likewise, children in the DIMS group had less axial elongation by 62% than those in the SV group (mean difference 0.34±0.04 mm, 95% CI 0.22 to 0.37, p<0.0001). 21.5% children who wore DIMS lenses had no myopia progression over 2 years, but only 7.4% for those who wore SV lenses.
CONCLUSIONS: Daily wear of the DIMS lens significantly retarded myopia progression and axial elongation in myopic children. Our results demonstrated simultaneous clear vision with constant myopic defocus can slow myopia progression. TRIAL REGISTRATION NUMBER: NCT02206217. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  myopia; myopia control; myopic defocus; simultaneous vision; spectacle lens

Year:  2019        PMID: 31142465     DOI: 10.1136/bjophthalmol-2018-313739

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  51 in total

1.  Safety of DIMS Spectacle Lenses and Atropine as Combination Therapy for Myopia Progression.

Authors:  Hakan Kaymak; Ann-Isabel Mattern; Birte Graff; Kai Neller; Achim Langenbucher; Berthold Seitz; Hartmut Schwahn
Journal:  Klin Monbl Augenheilkd       Date:  2022-08-25       Impact factor: 0.742

2.  Myopia Control With Multifocal Lens in School-Aged Children: A Meta-Analysis.

Authors:  Meilan Chen; Lu Xu; Hongyang Li; Fengping Cai; Hao Wang; Chun Hu; Yi Wu
Journal:  Front Pediatr       Date:  2022-06-20       Impact factor: 3.569

3.  Insight from OPN1LW Gene Haplotypes into the Cause and Prevention of Myopia.

Authors:  Maureen Neitz; Melissa Wagner-Schuman; Jessica S Rowlan; James A Kuchenbecker; Jay Neitz
Journal:  Genes (Basel)       Date:  2022-05-25       Impact factor: 4.141

4.  Biometric and refractive changes following the monocular application of peripheral myopic defocus using a novel augmented-reality optical system in adults.

Authors:  Ryo Kubota; Nabin R Joshi; Tara J Fitzgerald; Inna Samandarova; Maksud Oliva; Arkady Selenow; Amitava Gupta; Steven Ali; G Lynn Mitchell; Robert Chun; Kenneth J Ciuffreda
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

5.  Changes in the Choroidal Thickness of Children Wearing MiSight to Control Myopia.

Authors:  Francisco Luis Prieto-Garrido; Cesar Villa-Collar; Jose Luis Hernandez-Verdejo; Cristina Alvarez-Peregrina; Alicia Ruiz-Pomeda
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

6.  Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response.

Authors:  Henry H L Chan; Kai Yip Choi; Alex L K Ng; Bonnie N K Choy; Jonathan Cheuk Hung Chan; Sonia S H Chan; Serena Z C Li; Wing Yan Yu
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

Review 7.  Myopia: Mechanisms and Strategies to Slow Down Its Progression.

Authors:  Andrea Russo; Alessandro Boldini; Davide Romano; Giuseppina Mazza; Stefano Bignotti; Francesco Morescalchi; Francesco Semeraro
Journal:  J Ophthalmol       Date:  2022-06-14       Impact factor: 1.974

8.  The Effect of Corneal Refractive Power Area Changes on Myopia Progression during Orthokeratology.

Authors:  Minfeng Chen; Xinting Liu; Zhu Xie; Pengqi Wang; Miaoran Zheng; Xinjie Mao
Journal:  J Ophthalmol       Date:  2022-06-16       Impact factor: 1.974

9.  The impact of spectacle lenses for myopia control on visual functions.

Authors:  Yi Gao; Ee Woon Lim; Adeline Yang; Björn Drobe; Mark A Bullimore
Journal:  Ophthalmic Physiol Opt       Date:  2021-09-16       Impact factor: 3.992

10.  Is Peripheral Motion Detection Affected by Myopia?

Authors:  Junhan Wei; Deying Kong; Xi Yu; Lili Wei; Yue Xiong; Adeline Yang; Björn Drobe; Jinhua Bao; Jiawei Zhou; Yi Gao; Zhifen He
Journal:  Front Neurosci       Date:  2021-06-07       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.